APAC Cell & Gene Therapy Market 2020
Featuring 62 Cell & Gene Therapy companies from China, Taiwan, Korea, Japan, South Asia, SEA, and Australia!
Key Takeaways
- Insights on production processes, equipment, logistics and SCM services various BioPharmas and CMOs currently and plan to employ.
- Understand the facility expansion plans of key players in the APAC region.
- Identify potential clients who would be interested in your latest technology or service.
Report Snapshot
Featured Companies
PURCHASE YOUR REPORT HERE!
For offline payments or inquiries, kindly contact:
Kashmiira Nayar
e: kashmiira.nayar@imapac.com
t: +65 31090122
This license grants the right of use of the purchased report to a single recipient only. You may access the material on your computer, as and when required, for your own personal use.
Upto 3 users: This license grants the right of use of the purchased report by upto 3 users.
Upto 10 users: This license entitles the buyer of the report to share, distribute the report (either full or in part) with 10 other employees of the same firm /enterprise.
Section 1
• Preface
• Report Scope & Data Coverage
• IMAPAC’s Research Methodology
Section 2 – Company-Wise Analysis
• Company Overview
• GMP Certifications
• Facilities’ Size, Equipment, Capabilities etc.
• Expansion Plans
• Current Product Pipeline
• Stage of Development
• Production Capacity
• Platform Technologies
• Product Temperature Requirements
• Preferred Delivery and SCM methods
• Partnerships & Collaborations
• Financial Performance
• Company Highlights, News & Updates
• Interviews
Section 3: Region-Wise Data & Analysis {Regions Covered: China, Taiwan, Japan& Korea, India, Australia & Sea}
• Distribution of Cell & Gene Therapy Companies
• Targeted Disease Types
• Stage of clinical trial phase
• Allogenic vs Autolog0us Therapies
• Targeted Antigens
Section 4: Our Other Reports
• Bibiliography
• Disclaimer
• About Us
• Our Other Reports